da Silva, F. A., Stroka, A., & Fusco, V. (2019). PHARMACOLOGICAL ASPECTS OF THE MONOCLONAL ANTIBODY (NIVOLUMAB) USING THE PD-1 PATHWAY IN ANTITUMOR TREATMENT OF HODGKIN’S LYMPHOMA. Infarma - Pharmaceutical Sciences, 31(1), 13–19. https://doi.org/10.14450/2318-9312.v31.e1.a2019.pp13-19